Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat
- 1 November 1993
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 32 (6) , 425-433
- https://doi.org/10.1007/bf00685885
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- In vitro interactions between platinum analogues in human ovarian-carcinoma cell linesCancer Chemotherapy and Pharmacology, 1992
- Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic actionBiochemical Pharmacology, 1991
- Experimental and clinical status of intraperitoneal chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1990
- A Comparison of the Toxicity and Efficacy of Cisplatin and Carboplatin in Advanced Ovarian CancerActa Oncologica, 1989
- Carboplatin: current status and future prospectsCancer Treatment Reviews, 1988
- Carboplatin in combination therapy for ovarian cancerCancer Treatment Reviews, 1988
- Ovarian trials at the Royal MarsdenCancer Treatment Reviews, 1985
- Phase I study and pharmacokinetics of intraperitoneal carboplatinCancer Treatment Reviews, 1985
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984